Billionaire Who Rode Zoom’s 1,479% Stock Boom Builds Health Bets
- Samuel Chen has stakes in biotechs Acepodia, Polaris Group
- He earned as much as $2.2 billion from selling Zoom shares
This article is for subscribers only.
Samuel Chen’s early bet on Zoom Video Communications Inc. made him one of the pandemic economy’s big winners. For his latest act, the little-known Taiwanese billionaire is emerging as a major health-care investor.
His Digital Mobile Venture led a $100 million series D fundraising round this week for biotechnology firm Acepodia after previously investing in the US and Taiwan-based company in 2021.